Coral Laboratories Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Coral Laboratories announced that the Board of Directors of the Company at its meeting held on 13 July 2024, has recommended a Final dividend of Rs.2 per share (i.e.20%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

Coral Laboratories will hold a meeting of the Board of Directors of the Company on 13 July 2024.

Powered by Capital Market - Live News

Revenue from operations soared to Rs 28.88 crore in Q4 FY24 as against 11.43 crore in Q4 FY23.

Pre-tax profit was Rs 7.83 crore as compared with pre tax loss of Rs 1.62 crore in same quarter last year.

Total expenses jumped 62.73% YoY to Rs 23.14 crore in Q4 FY24. Cost of material consumed stood at Rs 13.10 crore (up 149.05% YoY), employee benefit expenses was at Rs 3.34 crore (up 28.96% YoY) during the period under review.

On full year basis, the company’s consolidated net profit surged to Rs 15.78 crore in FY24 as compared with Rs 6.44 crore in FY23. Revenue from operations increased 7.11% YoY to Rs 83.66 crore in FY24.

Coral Laboratories engaged into the manufacturing of pharmaceutical formulations. The company manufactures Generic – Branded, Herbal Medicines, etc. in the product categories of Non-Sterile, Sterile, Nutraceuticals, Otc + Lifestyle.

The counter hit 52 week high at Rs 541.40 in intraday today. It has market cap of Rs 190.78 crore.

Powered by Capital Market - Live News

Net profit of Coral Laboratories reported to Rs 5.79 crore in the quarter ended March 2024 as against net loss of Rs 0.89 crore during the previous quarter ended March 2023. Sales rose 152.53% to Rs 28.89 crore in the quarter ended March 2024 as against Rs 11.44 crore during the previous quarter ended March 2023.

For the full year,net profit rose 144.81% to Rs 15.79 crore in the year ended March 2024 as against Rs 6.45 crore during the previous year ended March 2023. Sales rose 7.09% to Rs 83.66 crore in the year ended March 2024 as against Rs 78.12 crore during the previous year ended March 2023.

Powered by Capital Market - Live News